Risk factors
Profusa (PFSA) risk factors
Item 1A of every Profusa, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors78 risks77 new57 dropped1 reworded
Profusa completed its transition from a special purpose acquisition company to an operating medical device firm commercializing its Lumee Oxygen and Glucose Platform. The risk profile shifted entirely from business combination mechanics to clinical trial progress, Nasdaq listing compliance, going concern doubts, and heavy operational losses.
Filed Apr 15, 2026 - FY2024 10-K risk factors58 risks
Profusa operates as a blank check company seeking an initial business combination, primarily in healthcare.
Filed Mar 31, 2025